| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39K | — | -15.2% |
| Cost of Revenue | $313K | — | +38.5% |
| R&D Expense | $3.6M | — | +32.5% |
| SG&A Expense | $1.9M | — | +3.2% |
| Operating Income | -$6.0M | — | -16.7% |
| Interest Expense | $495K | — | -1.0% |
| Net Income | -$4.4M | — | +12.9% |
| EPS (Basic) | -$0.08 | — | +72.4% |
| EPS (Diluted) | -$0.08 | — | +72.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $31K | -8.8% | -26.2% |
| Inventory | $1.5M | -3.6% | -10.1% |
| Current Assets | $27.7M | +340.9% | +233.0% |
| Total Assets | $29.8M | +248.5% | +187.2% |
| Current Liabilities | $12.2M | +5.6% | +60.8% |
| Total Liabilities | $19.3M | -5.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.1M | — | -62.7% |
| Capital Expenditures | $6K | — | +0.0% |
| Investing Cash Flow | -$6K | — | +0.0% |
| Financing Cash Flow | $27.6M | — | +675.9% |
| Free Cash Flow | -$6.1M | — | -62.6% |
| -44.3% |
| Stockholders' Equity | $10.2M | +183.6% | +141.9% |